Calluna Pharma As

This study is testing whether a new drug called CAL101 can help slow down the worsening of lung function in people with idiopathic pulmonary fibrosis (IPF), a serious scarring lung disease. About 150 adults with IPF will be randomly assigned to receive either the CAL101 infusion …